Goldman Sachs’s Inhibrx, Inc. Common Stock INBX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $13.2M | Buy |
|
|||||
|
2023
Q4 | $5.82M | Sell |
|
|||||
|
2023
Q3 | $2.93M | Sell |
|
|||||
|
2023
Q2 | $6.5M | Buy |
|
|||||
|
2023
Q1 | $3.31M | Buy |
|
|||||
|
2022
Q4 | $4.24M | Buy |
|
|||||
|
2022
Q3 | $2.79M | Buy |
|
|||||
|
2022
Q2 | $914K | Sell |
|
|||||
|
2022
Q1 | $3.22M | Buy |
|
|||||
|
2021
Q4 | $5.33M | Sell |
|
|||||
|
2021
Q3 | $5.48M | Buy |
|
|||||
|
2021
Q2 | $1.42M | Buy |
|
|||||
|
2021
Q1 | $855K | Buy |
|
|||||
|
2020
Q4 | $413K | Sell |
|
|||||
|
2020
Q3 | $1.61M | Buy |
|